50 ML immunoglobulin G, human 100 MG/ML Injection
RxNorm concept 1809414, clinical drug (scd). Prescribable name: immunoglobulin G, human 10 % in 50 ML Injection.
- RxCUI
- 1809414
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1809414 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
immunoglobulin G, human 10 % per 50 ML Injection; immunoglobulin G, human 5 GM per 50 ML Injection
Related concepts
- immunoglobulin G, human 100 MG/ML (SCDC, consists of)
- {1 (2.5 ML hyaluronidase, human recombinant 160 UNT/ML Injection) / 1 (50 ML immunoglobulin G, human 100 MG/ML Injection) } Pack (GPCK, contained in)
- {1 (2.5 ML hyaluronidase, human recombinant 160 UNT/ML Injection) / 1 (50 ML immunoglobulin G, human 100 MG/ML Injection) } Pack [Hyqvia 5 G / 50 ML Kit] (BPCK, contained in)
- Injection (DF, has dose form)
- 50 ML immunoglobulin G, human 100 MG/ML Injection [Bivigam] (SBD, has tradename)
- 50 ML immunoglobulin G, human 100 MG/ML Injection [Gammaked] (SBD, has tradename)
- 50 ML immunoglobulin G, human 100 MG/ML Injection [Flebogamma] (SBD, has tradename)
- 50 ML immunoglobulin G, human 100 MG/ML Injection [Octagam] (SBD, has tradename)
- 50 ML immunoglobulin G, human 100 MG/ML Injection [Privigen] (SBD, has tradename)
- 50 ML immunoglobulin G, human 100 MG/ML Injection [Gamunex] (SBD, has tradename)
- 50 ML immunoglobulin G, human 100 MG/ML Injection [Gammagard] (SBD, has tradename)
- 50 ML immunoglobulin G, human 100 MG/ML Injection [Gammaplex] (SBD, has tradename)
- 50 ML immunoglobulin G, human 100 MG/ML Injection [Gammagard ERC] (SBD, has tradename)
Linked data
NDCs
- 00944271605
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1809414 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1809414 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1809414. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.